Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solus Biotech
Bundang, South Korea
- Ownership
- Private
- Employees
- ~95
- Development stage
- Other
01
Overview
Solus Biotech, now part of Croda, supplies GMP-grade phospholipids and ceramides used as pharmaceutical excipients and in cosmeceuticals; products are commercial with established use in pharma and beauty applications[1][2][4][6].
- Therapeutic areas
- OtherDermatology
- Modalities
- PhospholipidCeramideRetinol (biotech-derived)Small molecule
- Industry
- Chemicals & Materials
02
Partnerships
Croda/Avanti (for lipid-based drug delivery research and manufacturing)[1][2][4]
Beyond the preview
Go deeper on Solus Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Solus Biotech.